Multidrug-Resistant Tuberculosis in Child Successfully Treated with 9-Month Drug Regimen
Jay AcharMédecins Sans Frontières, Tashkent, UzbekistanCatherine BerryImperial College London, LondonKrzysztof HerboczekMédecins Sans Frontières, Tashkent, UzbekistanNargiza ParpievaMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, UzbekistanMirzagaleb TillyashaykhovMédecins Sans Frontières, Tashkent, UzbekistanZinaida TigayMédecins Sans Frontières, London, UKAtadjan KhamraevMinistry of Health, Tashkent (N. Parpieva, M.N. Tillyashaykhov); Ministry of Health, Nukus, UzbekistanKalyan VelivelaMédecins Sans Frontières, London, UKJames A. SeddonImperial College London, LondonPhilipp du CrosImperial College London, London
ABI
Annotatsiya
To the Editor: Approximately 480,000 persons ac-quired multidrug-resistant tuberculosis (MDR TB) in 2013 (1). Of the 32,000 children who acquire MDR TB annually, few are identified and administered appropriate treatment (2). World Health Organization (WHO)–recommended treatment for MDR TB lasts 20–24 months, including 8 months of daily drug injections (3). Because many children have paucibacillary TB, a shorter protocol may be suffi-cient, especially for early or nonsevere disease.
Hali tarjima qilinmagan
Mavzular
Identifikatorlar
Iqtiboslar va manbalar
0 ta iqtibos5 ta foydalanilgan manba